Plant-based collagen alternative brand VeCollal has secured an investment from Seventure Partners to expand the roll-out of its solution internationally.

VeCollal, developed by Belgian nutraceuticals group Corpowell, mimics the natural amino acid profile of human collagen one-to-one. According to the company, this bio-identical foundation distinguishes VeCollal from incomplete animal collagen and simple ‘collagen boosters’ currently available on the market.

The brand has reported robust early momentum with partnerships secured in the US and Europe, including co-branding projects with brands such as Feel, Ringana, Aroma-Zone, Solaray, and Life Extension.

This latest capital injection validates the biomimetic technology and will accelerate its global roll-out. Isabelle de Cremoux, CEO of investment round leader Seventure Partners, said: “The VeCollal technology is not only substantially more CO2-efficient than animal collagen, but the company also has a scalable, B2B model with strong traction in the United States, Asia, and Europe”.

She added: “Our investment is intended to accelerate the global roll-out and establish VeCollal as the leading brand in biomimetic high-value, protein alternative ingredients”.

While animal collagen often requires 10–20g per day, VeCollal Type I is claimed to deliver visible skin health results with just 5g per day over eight weeks, including a 32.9% reduction in wrinkle depth. The company attributes this achievement to the combination of the solution’s biomimetic structure and AI-driven genetic activation.

Additionally, a Life Cycle Assessment of VeCollal shows that its fermentation-based process has an 83% lower CO2 emission footprint compared to traditional animal collagen.

Tony Van Campen, CEO and founder of Corpowell, said: “Throughout my career in the sector, I noticed we blindly accepted animal collagen, despite it being an incomplete protein”.

He added: “Consumers want sustainability and proven effectiveness. By replicating the amino acid structure of human collagen and activating its production in the body, we offer an intelligent alternative that genuinely makes a difference.”